NEW YORK – Thermo Fisher Scientific said this week that it has added a sales and customer services team that is based in Russia. The new team will serve customers of the firm's chromatography and mass spectrometry products that are located in Russia. Services will include installation and instrument maintenance.
Caris Life Sciences said this week that it has added Ohio State University and the National Cancer Center Japan to its Caris Precision Oncology Alliance (POA).
As a POA member, Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCC – James) will collaborate with other alliance members on research into biomarker-driven cancer care.
Caris says that NCC Japan — the largest cancer research organization in Japan with 43 affiliated network locations — will "add significant diversity in the patient populations being studied for impactful precision oncology research."
Caris' POA includes around 60 cancer centers and academic institutions, all of which have early access to Caris' genomic, transcriptomic, and proteomic profiling platform, Caris Molecular Intelligence, and the firm's extensive database.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on GenomeWeb.